Copy to clipboard 
Vy Spine received FDA clearance for its LumiVy OsteoVy PEKK Lumbar IBF.
The device is indicated for intervertebral body fusion for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis. The LumiVy OsteoVy PEKK Lumbar IBF combines the osseointegration properties of 3D-printed OXPEKK material and the novel OsteoVy lattice structure unique to Vy Spine.
The LumiVy OsteoVy PEKK Lumbar IBF is offered in numerous footprints and heights, ranging from 6mm to 21mm, addressing a full range of lumbar interbody approaches, including anterior, oblique anterior, lateral, oblique posterior, posterior and transforaminal. Additionally, the implants are available in a range of lordosis, and hyperlordosis. The system also features IBF-S implants, which have self-drilling screws to aid in anchoring the device directly to the bone.
OXPEKK has demonstrated bone ingrowth, no radiographic interference, no fibrotic tissue membrane formation, a significant increase in bony apposition over time, and significantly higher push-out strength compared to standard PEEK. In addition to these product benefits, OXPEKK is bacterostatic and an ideal option for patients with metal hypersensitivity. Vy Spine’s proprietary OsteoVy lattice structure aids in bony integration as well as wicking, PEKK being a hydrophilic material.
“The LumiVy OsteoVy PEKK Lumbar IBF clearance is another product in a long line of Vy Spine implants which will utilize the unique qualities of our proprietary OsteoVy PEKK designs,” said Bret Berry, President of Product Development for Vy Spine. “As we researched OXPEKK and its unique characteristics, we found that this composition accomplishes what PEEK cannot. We are excited about the OXPEKK material and our continued partnership with Oxford Performance Materials.”
“We are thrilled that Vy Spine has reached this important milestone with its second OsteoFab product approval,” said Scott DeFelice, CEO of Oxford Performance Materials. “We are confident that the combination of OPM’s novel 3D printed PEKK technology and Vy Spine’s unique designs & experience within the spine marketplace will drive substantial adoption of this best-in-class solution.”
Source: Vy Spine, LLC.
Vy Spine received FDA clearance for its LumiVy OsteoVy PEKK Lumbar IBF.
The device is indicated for intervertebral body fusion for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis. The LumiVy OsteoVy PEKK Lumbar IBF combines...
Vy Spine received FDA clearance for its LumiVy OsteoVy PEKK Lumbar IBF.
The device is indicated for intervertebral body fusion for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis. The LumiVy OsteoVy PEKK Lumbar IBF combines the osseointegration properties of 3D-printed OXPEKK material and the novel OsteoVy lattice structure unique to Vy Spine.
The LumiVy OsteoVy PEKK Lumbar IBF is offered in numerous footprints and heights, ranging from 6mm to 21mm, addressing a full range of lumbar interbody approaches, including anterior, oblique anterior, lateral, oblique posterior, posterior and transforaminal. Additionally, the implants are available in a range of lordosis, and hyperlordosis. The system also features IBF-S implants, which have self-drilling screws to aid in anchoring the device directly to the bone.
OXPEKK has demonstrated bone ingrowth, no radiographic interference, no fibrotic tissue membrane formation, a significant increase in bony apposition over time, and significantly higher push-out strength compared to standard PEEK. In addition to these product benefits, OXPEKK is bacterostatic and an ideal option for patients with metal hypersensitivity. Vy Spine’s proprietary OsteoVy lattice structure aids in bony integration as well as wicking, PEKK being a hydrophilic material.
“The LumiVy OsteoVy PEKK Lumbar IBF clearance is another product in a long line of Vy Spine implants which will utilize the unique qualities of our proprietary OsteoVy PEKK designs,” said Bret Berry, President of Product Development for Vy Spine. “As we researched OXPEKK and its unique characteristics, we found that this composition accomplishes what PEEK cannot. We are excited about the OXPEKK material and our continued partnership with Oxford Performance Materials.”
“We are thrilled that Vy Spine has reached this important milestone with its second OsteoFab product approval,” said Scott DeFelice, CEO of Oxford Performance Materials. “We are confident that the combination of OPM’s novel 3D printed PEKK technology and Vy Spine’s unique designs & experience within the spine marketplace will drive substantial adoption of this best-in-class solution.”
Source: Vy Spine, LLC.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
